Apricot Capital (Shanghai) Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Investments
  • 67

  • Portfolio
  • 47

  • Exits
  • 7


Apricot Capital (Shanghai) General Information

Company Description

Founded in 2015, Apricot Capital (Shanghai) is a venture capital firm headquartered in Shanghai, China. It seeks to make investments in biopharmaceuticals, medical devices, and medical diagnostics and services sectors.

Business Details

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • No. 1479 Fuxing Middle Road
  • Xuhui District
  • Shanghai
  • China
+86 021 0000 0000

Apricot Capital (Shanghai) Investments (67)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Simcere Zaiming 25-Feb-2024 Early Stage VC 00000 Drug Discovery Generating Revenue
Zhonghe Gene 29-Jan-2024 00000 00000 Biotechnology Generating Revenue
Yiteng Medical 19-Jan-2024 00000 00000 Electrical Equipment Generating Revenue
Sianran 21-Aug-2023 0000 00000 Diagnostic Equipment Startup
Taichu Biotechnology 08-May-2023 00000 00000 000.00 Biotechnology Generating Revenue
Yiteng Medical 03-Apr-2023 00000 00000 0000 Electrical Equipment Generating Revenue
Bio-Link (Shanghai) 20-Feb-2023 00000 00000 Medical Supplies Generating Revenue
Zhiran Medical 06-Jan-2023 00000 00000 Therapeutic Devices Startup
Arnatar Therapeutics 19-Sep-2022 Seed Round 000.00 Drug Discovery Generating Revenue
LinkZill 05-Sep-2022 Early Stage VC 00.000 Specialty Chemicals Generating Revenue
You’re viewing 10 of 67 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apricot Capital (Shanghai) Exits (7)

Company Name Exit Date Exit Type Exit Size
MicroPort Electrophysiology 30-Aug-2022 IPO 00000
Shengsheng 09-Nov-2021 000000000 00000000 000.00
Guobang Pharmaceutical 02-Aug-2021 000 00000
Akeso Biopharma 24-Apr-2020 000 00000
TopAlliance 24-Dec-2018 IPO 00000
MicroPort CardioFlow 23-Mar-2018 Secondary Transaction - Private
You’re viewing 6 of 7 exits. Get the full list »

Apricot Capital (Shanghai) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Apricot Capital (Shanghai) Management, Team & Partners (5)

Name Title Deals Funds Boards Office
Haigang Chen Managing Partner 0 0 Shanghai, China
Weixiong Mao Managing Partner Shanghai, China
Wenyi Liu Ph.D Managing Partner Shanghai, China
Xu Tao Partner Shanghai, China
Jing Qiang Managing Partner 0 0 0 Shanghai, China
To view Apricot Capital (Shanghai)’s complete team members history, request access »

Apricot Capital (Shanghai) Co-Investors (89)

Name With Exits Lead Partner Series Industry
GL Ventures 4 0 Series chart Industry bar
Huagai Capital 0 0 Series chart Industry bar
IDG Capital 0 Series chart Industry bar
Legend Capital 0 0 Series chart Industry bar
Oriza Holdings 0 Series chart Industry bar
You’re viewing 5 of 89 co-investors. Get the full list »

Apricot Capital (Shanghai) FAQs

  • What is Apricot Capital (Shanghai)?

    Founded in 2015, Apricot Capital (Shanghai) is a venture capital firm headquartered in Shanghai, China.

  • When was Apricot Capital (Shanghai) founded?

    Apricot Capital (Shanghai) was founded in 2015.

  • Where is Apricot Capital (Shanghai) headquartered?

    Apricot Capital (Shanghai) is headquartered in Shanghai, China.

  • What is Apricot Capital (Shanghai)'s total asset value?

    Apricot Capital (Shanghai) has around 00000 in total assets under management.

  • How many investments has Apricot Capital (Shanghai) made?

    Apricot Capital (Shanghai) has made 67 investments.

  • What has Apricot Capital (Shanghai) invested in?

    Apricot Capital (Shanghai) has made numerous investments in companies like Simcere Zaiming, Zhonghe Gene, and Yiteng Medical within the Drug Discovery, Biotechnology, and Electrical Equipment industries.

  • What has Apricot Capital (Shanghai) invested in recently?

    Apricot Capital (Shanghai)'s latest investment was on 25-Feb-2024 in Simcere Zaiming, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »